Table of Contents Author Guidelines Submit a Manuscript
Gastroenterology Research and Practice
Volume 2017 (2017), Article ID 5080361, 9 pages
https://doi.org/10.1155/2017/5080361
Research Article

Multimodality Treatment Including Triplet Regimen as First-Line Chemotherapy May Improve Prognosis of Serum AFP-Elevated Gastric Cancer with Liver Metastasis

Department of Gastrointestinal Oncology, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Cancer Hospital & Institute, No. 52, Fucheng Road, Haidian District, Beijing 100142, China

Correspondence should be addressed to Xiaotian Zhang

Received 31 August 2017; Accepted 27 November 2017; Published 24 December 2017

Academic Editor: Haruhiko Sugimura

Copyright © 2017 Yakun Wang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. El-Bahrawy, “Alpha-fetoprotein-producing non-germ cell tumours of the female genital tract,” European Journal of Cancer, vol. 46, no. 8, pp. 1317–1322, 2010. View at Publisher · View at Google Scholar · View at Scopus
  2. D. Li and S. Satomura, “Biomarkers for hepatocellular carcinoma (HCC): an update,” Advances in Experimental Medicine and Biology, vol. 867, pp. 179–193, 2015. View at Publisher · View at Google Scholar · View at Scopus
  3. M. J. Murray, R. A. Huddart, and N. Coleman, “The present and future of serum diagnostic tests for testicular germ cell tumours,” Nature Reviews. Urology, vol. 13, no. 12, pp. 715–725, 2016. View at Publisher · View at Google Scholar · View at Scopus
  4. E. Alpert, V. W. Pinn, and K. J. Isselbacher, “Alpha-fetoprotein in a patient with gastric carcinoma metastatic to the liver,” The New England Journal of Medicine, vol. 285, no. 19, pp. 1058-1059, 1971. View at Publisher · View at Google Scholar
  5. X. Liu, Y. Cheng, W. Sheng et al., “Clinicopathologic features and prognostic factors in alpha-fetoprotein-producing gastric cancers: analysis of 104 cases,” Journal of Surgical Oncology, vol. 102, no. 3, pp. 249–255, 2010. View at Publisher · View at Google Scholar · View at Scopus
  6. D. Wang, C. Li, Y. Xu et al., “Clinicopathological characteristics and prognosis of alpha-fetoprotein positive gastric cancer in Chinese patients,” International Journal of Clinical and Experimental Pathology, vol. 8, no. 6, pp. 6345–6355, 2015. View at Google Scholar
  7. H. J. Lin, Y. H. Hsieh, W. L. Fang, K. H. Huang, and A. F. Li, “Clinical manifestations in patients with alpha-fetoprotein-producing gastric cancer,” Current Oncology, vol. 21, no. 3, pp. e394–e399, 2014. View at Publisher · View at Google Scholar · View at Scopus
  8. Y. Adachi, J. Tsuchihashi, N. Shiraishi, K. Yasuda, T. Etoh, and S. Kitano, “AFP-producing gastric carcinoma: multivariate analysis of prognostic factors in 270 patients,” Oncology, vol. 65, no. 2, pp. 95–101, 2003. View at Publisher · View at Google Scholar · View at Scopus
  9. M. Inoue, T. Sano, A. Kuchiba, H. Taniguchi, T. Fukagawa, and H. Katai, “Long-term results of gastrectomy for alpha-fetoprotein-producing gastric cancer,” The British Journal of Surgery, vol. 97, no. 7, pp. 1056–1061, 2010. View at Publisher · View at Google Scholar · View at Scopus
  10. M. Kochi, M. Fujii, T. Kaiga et al., “FLEP chemotherapy for alpha-fetoprotein-producing gastric cancer,” Oncology, vol. 66, no. 6, pp. 445–449, 2004. View at Publisher · View at Google Scholar · View at Scopus
  11. T. J. Vogl, T. Gruber-Rouh, K. Eichler et al., “Repetitive transarterial chemoembolization (TACE) of liver metastases from gastric cancer: local control and survival results,” European Journal of Radiology, vol. 82, no. 2, pp. 258–263, 2013. View at Publisher · View at Google Scholar · View at Scopus
  12. A. Ooi, I. Nakanishi, N. Sakamoto et al., “Alpha-fetoprotein (AFP)-producing gastric carcinoma. Is it hepatoid differentiation?” Cancer, vol. 65, no. 8, pp. 1741–1747, 1990. View at Publisher · View at Google Scholar
  13. N. Koide, A. Nishio, J. Igarashi, S. Kajikawa, W. Adachi, and J. Amano, “α-Fetoprotein-producing gastric cancer: histochemical analysis of cell proliferation, apoptosis, and angiogenesis,” The American Journal of Gastroenterology, vol. 94, no. 6, pp. 1658–1663, 1999. View at Publisher · View at Google Scholar
  14. E. Nagai, T. Ueyama, T. Yao, and M. Tsuneyoshi, “Hepatoid adenocarcinoma of the stomach. A clinicopathologic and immunohistochemical analysis,” Cancer, vol. 72, no. 6, pp. 1827–1835, 1993. View at Publisher · View at Google Scholar
  15. V. Trompetas, N. Varsamidakis, K. Frangia, V. Polimeropoulos, and E. Kalokairinos, “Gastric hepatoid adenocarcinoma and familial investigation: does it always produce alpha-fetoprotein?” European Journal of Gastroenterology & Hepatology, vol. 15, no. 11, pp. 1241–1244, 2003. View at Publisher · View at Google Scholar · View at Scopus
  16. C. G. Bergstrand and B. Czar, “Demonstration of a new protein fraction in serum from the human fetus,” Scandinavian Journal of Clinical and Laboratory Investigation, vol. 8, no. 2, p. 174, 1956. View at Publisher · View at Google Scholar · View at Scopus
  17. J. S. Su, Y. T. Chen, R. C. Wang, C. Y. Wu, S. W. Lee, and T. Y. Lee, “Clinicopathological characteristics in the differential diagnosis of hepatoid adenocarcinoma: a literature review,” World Journal of Gastroenterology, vol. 19, no. 3, pp. 321–327, 2013. View at Publisher · View at Google Scholar · View at Scopus
  18. H. Ishikura, Y. Fukasawa, K. Ogasawara, T. Natori, Y. Tsukada, and M. Aizawa, “An AFP-producing gastric carcinoma with features of hepatic differentiation. A case report,” Cancer, vol. 56, no. 4, pp. 840–848, 1985. View at Publisher · View at Google Scholar
  19. T. Motoyama, K. Aizawa, H. Watanabe, M. Fukase, and K. Saito, “α-Fetoprotein producing gastric carcinomas: a comparative study of three different subtypes,” Pathology International, vol. 43, no. 11, pp. 654–661, 1993. View at Publisher · View at Google Scholar
  20. J. Yang, R. Wang, W. Zhang, W. Zhuang, M. Wang, and C. Tang, “Clinicopathological and prognostic characteristics of hepatoid adenocarcinoma of the stomach,” Gastroenterology Research and Practice, vol. 2014, Article ID 140587, 5 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus
  21. S. Hirajima, S. Komatsu, D. Ichikawa et al., “Liver metastasis is the only independent prognostic factor in AFP-producing gastric cancer,” World Journal of Gastroenterology, vol. 19, no. 36, pp. 6055–6061, 2013. View at Publisher · View at Google Scholar · View at Scopus
  22. Y. Yamada, K. Higuchi, K. Nishikawa et al., “Phase III study comparing oxaliplatin plus S-1 with cisplatin plus S-1 in chemotherapy-naïve patients with advanced gastric cancer,” Annals of Oncology, vol. 26, no. 1, pp. 141–148, 2014. View at Publisher · View at Google Scholar
  23. L. Shen, Y. S. Shan, H. HM et al., “Management of gastric cancer in Asia: resource-stratified guidelines,” The Lancet Oncology, vol. 14, no. 12, pp. e535–e547, 2013. View at Publisher · View at Google Scholar · View at Scopus
  24. S. K. Baek, S. W. Han, O. DY, S. A. Im, T. Y. Kim, and Y. J. Bang, “Clinicopathologic characteristics and treatment outcomes of hepatoid adenocarcinoma of the stomach, a rare but unique subtype of gastric cancer,” BMC Gastroenterology, vol. 11, no. 1, p. 56, 2011. View at Publisher · View at Google Scholar · View at Scopus
  25. Y. C. Chang, N. Nagasue, H. Kohno, K. Ohiwa, A. Yamanoi, and T. Nakamura, “Xenotransplantation of alpha-fetoprotein-producing gastric cancers into nude mice. Characteristics and responses to chemotherapy,” Cancer, vol. 69, no. 4, pp. 872–877, 1992. View at Publisher · View at Google Scholar
  26. Y. U. Fang, L. Wang, N. Yang, X. Gong, Y. U. Zhang, and S. Qin, “Successful multimodal therapy for an α-fetoprotein-producing gastric cancer patient with simultaneous liver metastases,” Oncology Letters, vol. 10, no. 5, pp. 3021–3025, 2015. View at Publisher · View at Google Scholar · View at Scopus
  27. S. Nakao, B. Nakata, M. Tendo et al., “Salvage surgery after chemotherapy with S-1 plus cisplatin for α-fetoprotein-producing gastric cancer with a portal vein tumor thrombus: a case report,” BMC Surgery, vol. 15, no. 1, p. 5, 2015. View at Publisher · View at Google Scholar · View at Scopus
  28. S. Kamei, K. Kono, H. Amemiya et al., “Evaluation of VEGF and VEGF-C expression in gastric cancer cells producing α-fetoprotein,” Journal of Gastroenterology, vol. 38, no. 6, pp. 540–547, 2003. View at Publisher · View at Google Scholar
  29. A. Tanaka, R. Takeda, S. Mukaihara et al., “Tumor thrombi in the portal vein system originating from gastrointestinal tract cancer,” Journal of Gastroenterology, vol. 37, no. 3, pp. 220–228, 2002. View at Publisher · View at Google Scholar · View at Scopus
  30. W. Meng, X. Li, Z. Bai et al., “Silencing alpha-fetoprotein inhibits VEGF and MMP-2/9 production in human hepatocellular carcinoma cell,” PLoS One, vol. 9, no. 2, article e90660, 2014. View at Publisher · View at Google Scholar · View at Scopus
  31. X. R. Zhu, M. L. Zhu, Q. Wang et al., “A case report of targeted therapy with apatinib in a patient with advanced gastric cancer and high serum level of alpha-fetoprotein,” Medicine, vol. 95, no. 37, article e4610, 2016. View at Publisher · View at Google Scholar · View at Scopus
  32. J. Ma, H. Shen, L. Kapesa, and S. Zeng, “Lauren classification and individualized chemotherapy in gastric cancer,” Oncology Letters, vol. 11, no. 5, pp. 2959–2964, 2016. View at Publisher · View at Google Scholar · View at Scopus